Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Karine Barthélémy"'
Autor:
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, Paul-Rémi Petit, Magali Gilles, Grégory Moureau, Karine Barthélémy, Caroline Laprie, Thanaporn Wattanakul, Palang Chotsiri, Richard M. Hoglund, Joel Tarning, Laurent Fraisse, Peter Sjö, Charles E. Mowbray, Fanny Escudié, Ivan Scandale, Eric Chatelain, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
Publikováno v:
EBioMedicine, Vol 82, Iss , Pp 104148- (2022)
Summary: Background: To address the emergence of SARS-CoV-2, multiple clinical trials in humans were rapidly started, including those involving an oral treatment by nitazoxanide, despite no or limited pre-clinical evidence of antiviral efficacy. Meth
Externí odkaz:
https://doaj.org/article/2c868ce6fdee4c09b5bfe87564b64a94
Autor:
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, Géraldine Piorkowski, Karine Barthélémy, Caroline Laprie, Bruno Coutard, Jérémie Guedj, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Favipiravir has broad-spectrum antiviral activity against a variety of RNA viruses. Here the authors investigate the safety, pharmacokinetics and anti-SARS-CoV-2 efficacy of different drug dosage in the a Syrian hamster model of infection and, combin
Externí odkaz:
https://doaj.org/article/28b65fe72e8643d09a5316e736cd7471
Autor:
Franck Touret, Guillaume Martin-Blondel, Xavier de Lamballerie, Axelle Dupont, Jacques Izopet, France Mentré, Nassim Kamar, Brigitte Autran, Gilles Paintaud, Sophie Caillard, Christophe Richez, Lionel Couzi, Aliénor Xhaard, Zora Marjanovic, Jerome Avouac, Caroline Jacquet, Dany Anglicheau, Morgane Cheminant, Yazdan Yazdanpanah, Stéphanie N’Guyen, Benjamin Terrier, Jacques Eric Gottenberg, Caroline Besson, Sophie Letrou, Sabrina Kali, Denis Angoulvant, Karine Barthélémy, Stéphane Priet, Elif Nurtop, Ventzislava Petrov Sanchez, Coralie Tardivon, Gilles Blancho, Amandine Le Bourgeois, Vincent Lévy
Publikováno v:
Journal of Infection. 86:e126-e129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a5225a06fcb2f73bca99538ea6ecb20
https://doi.org/10.1016/j.jinf.2023.02.002
https://doi.org/10.1016/j.jinf.2023.02.002
Autor:
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, Paul-Rémi Petit, Magali Gilles, Grégory Moureau, Karine Barthélémy, Caroline Laprie, Thanaporn Wattanakul, Palang Chotsiri, Richard M. Hoglund, Joel Tarning, Laurent Fraisse, Peter Sjö, Charles E. Mowbray, Fanny Escudié, Ivan Scandale, Eric Chatelain, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
To address the emergence of SARS-CoV-2, multiple clinical trials in humans were rapidly started, including those involving an oral treatment by nitazoxanide, despite no or limited pre-clinical evidence of antiviral efficacy.In this work, we present a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df41ae06c9c8f4702f1c8e860c49c6fd
https://ora.ox.ac.uk/objects/uuid:4ea7c3fb-47f4-435c-9e65-01350851c272
https://ora.ox.ac.uk/objects/uuid:4ea7c3fb-47f4-435c-9e65-01350851c272
Autor:
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, Paul-Rémi Petit, Magali Gilles, Grégory Moureau, Karine Barthélémy, Caroline Laprie, Thanaporn Wattanakul, Palang Chotsiri, Richard M. Hoglund, Joel Tarning, Fanny Escudié, Ivan Scandale, Eric Chatelain, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
To address the emergence of SARS-CoV-2, multiple clinical trials in humans were rapidly started, including those involving an oral treatment by nitazoxanide, despite no or limited pre-clinical evidence of antiviral efficacy. In this work, we present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3209adb8d92890518299d4bbd9bf8cbe
https://doi.org/10.1101/2021.12.17.473113
https://doi.org/10.1101/2021.12.17.473113
Autor:
Bruno Lacarelle, Romain Guilhaumou, Renée Ugdonne, Caroline Solas, Karine Barthélémy, Natalia Doudka, Manon Basso, Madeleine Giocanti, Olivier Blin
Publikováno v:
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (4), pp.570-576. ⟨10.1097/FTD.0000000000000836⟩
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (4), pp.570-576. ⟨10.1097/FTD.0000000000000836⟩
International audience; Therapeutic drug monitoring of hydroxychloroquine (HCQ) has been recommended to optimize the treatment of patients with COVID-19. The authors describe an ultrahigh-performance liquid chromatography tandem spectrometry method d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b87d814d2fbfbe6645817d16c97f947
https://hal.archives-ouvertes.fr/hal-03597962
https://hal.archives-ouvertes.fr/hal-03597962
Autor:
Joana Rocha-Pereira, Karine Barthélémy, Sebastiaan ter Horst, Kai Dallmeier, Pieter Annaert, Laurens Liesenborghs, Lindsey Bervoets, Caroline Solas, Bart Hens, Patrick Augustijns, Robbert Boudewijns, Tina Van Buyten, Juanita Pang, Judith Breuer, Elisabeth Heylen, Carolien De Keyzer, Birgit Weynand, Hendrik Jan Thibaut, Lana Langendries, Rana Abdelnabi, Isabel Spriet, Jasper Rymenants, Johan Neyts, Valentijn Vergote, Xin Zhang, Nick Verougstraete, Greetje Vande Velde, Sofie Jacobs, Leen Delang, Christopher Cawthorne, Laura Seldeslachts, Elke Maas, Jens Wouters, Rachel Williams, Suzanne J.F. Kaptein
Publikováno v:
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America
Significance The previous lack of consensus around the use of hydroxychloroquine for COVID-19 patients underlines the need to thoroughly assess the in vivo efficacy of drugs against SARS-CoV-2. Small animal infection models, such as the hamster model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::053b1bd09b99aeed71867f4a1db0d017
Autor:
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, Géraldine Piorkowski, Karine Barthélémy, Caroline Laprie, Bruno Coutard, Jérémie Guedj, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Despite no or limited pre-clinical evidence, repurposed drugs are massively evaluated in clinical trials to palliate the lack of antiviral molecules against SARS-CoV-2. Here we use a Syrian hamster model to assess the antiviral efficacy of favipiravi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a5e4a4dc0375e89286e18807f878cad3
https://pubmed.ncbi.nlm.nih.gov/33741945
https://pubmed.ncbi.nlm.nih.gov/33741945
Autor:
Antoine Nougairède, Caroline Solas, Paul Rémi Petit, Xavier de Lamballerie, Francois-Xavier Mahon, Maxime Cochin, Magali Gilles, Karine Barthélémy, Jean-Sélim Driouich, Denis Malvy, Gregory Moureau, Franck Touret
Publikováno v:
Antiviral Research
Antiviral Research, Elsevier Masson, 2021, 193, pp.105137. ⟨10.1016/j.antiviral.2021.105137⟩
bioRxiv
Antiviral Research, Elsevier Masson, 2021, 193, pp.105137. ⟨10.1016/j.antiviral.2021.105137⟩
bioRxiv
Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b654d63c47d8e02606962d6c0b32c2
https://doi.org/10.1016/j.antiviral.2021.105137
https://doi.org/10.1016/j.antiviral.2021.105137